This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
How to Bounce Back from Adversity (Spanish version)
Margolis, Joshua D.; Stoltz, Paul G.Article HBS-R1001ELeadership and People Managementhow to manage corporate transformation, what we understand about personal resilience, whether the United States can reclaim its leadership role in innovation and invention, and how executives in strategy and marketing are reconceiving the work they do.Starting at €8.20
-
Workplace Safety at Alcoa (A) (Spanish Version)
Clark, Kim B.; Margolis, Joshua D.Case HBS-604S19Service and Operations ManagementExamina el desafío que enfrentan los gerentes de una planta de fabricación de aluminio grande en su campaña para mejorar la seguridad en el trabajo. El CEO de la compañía ha hecho de la seguridad una prioridad. La planta ha hecho grandes progresos en la reducción de la tasa de lesiones, pero ahora se enfrenta a la necesidad de acelerar su mejora. Para ello se requiere el director de seguridad a tener en cuenta el progreso hasta la fecha y analiza...Starting at €8.20
-
Olympia Machine Company, Inc. (Spanish Version)
Cespedes, Frank V.; Shapiro, Benson P.Case HBS-709S04MarketingEl equipo de dirección de un proveedor de equipos industriales está debatiendo método para compensar los vendedores de la compañía. Diferentes ejecutivos han ofrecido diferentes alternativas al método actual de salario fijo más los gastos. Cada opción tiene diferentes implicaciones para la estrategia de negocios, organización, sistemas de control, y los requisitos de gestión de ventas. Como resultado, el caso plantea cuestiones y análisis pertine...Starting at €8.20
-
SafeBlend Fracturing (Spanish version)
Shapiro, Benson P.; Cespedes, Frank V.; Zalosh, AlisaCase HBS-915S14MarketingThe CEO of SafeBlend Technologies must set a price for the company's environmentally friendly fracturing fluid additive. The firm is negotiating a new contract with its biggest client, Bristol Natural Gas. For the past two years, SafeBlend has been the sole provider of additives to Bristol due to aggressive negotiation and limited competition. New competitors are entering the market, and the CEO believes one competitor is prepared to offer Bristo...Starting at €8.20
-
Avi Kremer (Spanish Version)
Margolis, Joshua D.; Wetzel, MarkCase HBS-417S12Leadership and People ManagementSi usted fue diagnosticado con una enfermedad terminal, ¿cómo respondería y qué haría usted con su tiempo restante? Avi Kremer contempla cuatro opciones para dedicarse por 18 meses después de ser diagnosticado con ELA. Su experiencia hasta ahora y las elecciones que se enfrenta a una visión de crianza en la construcción de la resiliencia y la búsqueda de propósito. Los documentos del caso la historia personal de Kremer, antes y después del diagnó...Starting at €8.20
-
Cumberland Metal Industries (C): Model Year 1979 Negotiations with Beta Motors (Spanish Version)
Shapiro, Benson P.; Cline, Craig E.Case HBS-518S26MarketingDiseñado como un caso (b) la clase lado de salida después de la discusión de la (A) y.Starting at €5.74
-
Milford Industries (A) (Spanish version)
Shapiro, Benson P.; Dolan, Robert J.Case HBS-502S06MarketingThe new district sales manager for a tool company must determine how to get his district "back on track." The case presents various qualitative and quantitative information on the salespeople. Teaching objectives include the specification of the tasks of a district sales manager and the sales analysis helpful to him in his job. A rewritten version of an earlier case series.Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Do Well by Doing Good Don't Count on It
Margolis, Joshua D.; Elfenbein, Hillary AngerArticle HBS-F0801D-EResearch over 35 years shows only a weak link between socially responsible corporate behavior and good financial performance. However, there's no evidence of risk in doing good, only in being exposed for misdeeds.Starting at €8.20
-
Feedback and Coaching Workshop, Teaching Note
Margolis, Joshua D.; Mayo, Anthony J.Teaching Note HBS-413016-ELeadership and People ManagementTeaching Note for 412039, 412040, 412041, 412042, 412045 and 412046.Starting at €0.00